Leland Gershell

2017 - Tonix Pharmaceuticals Holding

In 2017, Leland Gershell earned a total compensation of $21K as Former Chief Financial Officer at Tonix Pharmaceuticals Holding, a 95% decrease compared to previous year.

Compensation breakdown

Other$21,000
Total$21,000

Gershell received $21K in other compensation, accounting for 100% of the total pay in 2017.

Rankings

In 2017, Leland Gershell's compensation ranked 14,601st out of 14,666 executives tracked by ExecPay.

ClassificationRankingPercentile
All
14,601
out of 14,666
0th
Division
Manufacturing
5,747
out of 5,772
0th
Major group
Chemicals And Allied Products
2,069
out of 2,075
0th
Industry group
Drugs
1,725
out of 1,731
0th
Industry
Pharmaceutical Preparations
1,329
out of 1,333
0th
Source: SEC filing on April 19, 2018.

Gershell's colleagues

We found three more compensation records of executives who worked with Leland Gershell at Tonix Pharmaceuticals Holding in 2017.

2017

Seth Lederman

Tonix Pharmaceuticals Holding

Chief Executive Officer

2017

Gregory Sullivan

Tonix Pharmaceuticals Holding

Chief Medical Officer

2017

Bradley Saenger

Tonix Pharmaceuticals Holding

Chief Financial Officer

You may also like